Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BNOS 2022 | Redefining glioblastoma to improve patient outcomes

Whilst the perceived overall survival of glioblastoma tends to be inferior to other cancers, patients outcomes are similar when compared to other stage 4 cancers. Simon Lammy, MBBS, MRCS (Ed), MFST (Ed), University of Glasgow, Glasgow, UK, describes strategies to optimize clinical outcomes in patients with glioblastoma. Full access to the brain remains a challenge even with detailed MRI and reassessing the nature of the disease itself may provide fresh perspectives in treating glioblastoma. This interview took place at the British Neuro-Oncology Society (BNOS) Annual Meeting 2022.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.